Product NDC: | 50458-805 |
Proprietary Name: | Ditropan |
Non Proprietary Name: | oxybutynin chloride |
Active Ingredient(s): | 5 mg/1 & nbsp; oxybutynin chloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50458-805 |
Labeler Name: | Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020897 |
Marketing Category: | NDA |
Start Marketing Date: | 19990626 |
Package NDC: | 50458-805-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50458-805-01) |
NDC Code | 50458-805-01 |
Proprietary Name | Ditropan |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50458-805-01) |
Product NDC | 50458-805 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | oxybutynin chloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19990626 |
Marketing Category Name | NDA |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | OXYBUTYNIN CHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |